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This study investigated the activity of aqueous and corn steep liquor (CSL) extracts of Ficus exaperasta,
Annona muricata and Azadirachta indica against Candida spp. isolated from high vaginal swab sam-
ples. Phytochemical screening of the plants was done using standard methods, the antifungal activity
of the plant’s extracts and standard drugs were tested against isolates of Candida spp. using the agar
well diffusion method; the minimum inhibitory concentration (MIC) and minimum fungicidal con-
centration (MFC) were also determined using microdilution standardized techniques. Phytochemical
screening of the aqueous and CSL extracts of the plants revealed the presence of tannin, saponin,
flavonoids, and terpenoids. Among the five Candida strain isolates, the zone of inhibition produced
by the plant extracts against C. albicans shows a range of 0-18.3 mm; C. krusei (strain A): 5.1-24.5 mm; C.
krusei (strain B): 0-18.0 mm; C. kefyr (strain A): 6.1-27.5 mm; and C. kefyr (strain B): 0-22.0 mm. The CSL
extract had higher inhibitory action compared with aqueous extract, also F. exasperata and A. muricata
gave better antifungal activity against the tested Candida strains. The MIC of the aqueous and CSL
extracts of the F. exasperata ranged between 6.25-12.50 mg/mL; A. muricata: 3.125-12.500 mg/mL, while
the aqueous and CSL extracts of A. indica was found to have no activity at all the tested concentrations
against C. albicans, C. krusei (strain A) and C. krusei (strain B), similar observation for the MFC. This
study proved the antifungal efficacy of aqueous and CSL extracts of F. exasperata, A. muricata, and A.
indica against isolates of Candida species which are usually implicated in candidiasis.
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1. INTRODUCTION
Fungal infections continue to be a source of concern for pub-
lic health as it is known to affect many people worldwide.
In recent times, infections caused by fungi are considered to
be the fourth foremost causes of infections spread by blood
where the prominent fungi concerned are those of Candida
species (Pierce, 2005; Tsai et al., 2013). Candida spp. is one of
the common fungal infection plaguing humans. These yeast
species are characterized by a thin cell wall, ovoid cells that are
typically 3-5 µm in diameter, often forming the normal flora of
skin, mouth, vagina, and intestine. They are also known to be
opportunistic pathogens that infect people with low immunity
(Calderone and Fonzi, 2001; Rahman et al., 2011). Candida
remains the major fungal pathogen responsible for the major-
ity of human infections ranging from localized superficial to
systemic candidiasis. It accounts for over 50% of all cases in
the world, while an increase in the prevalence of yeast infec-
tions caused by Candida species other than C. albicans such as
C. glabrata, C. krusei, C. tropicalis, and C. parapsilosis has been
reported in different parts of the world (Pfaller and Diekema,
2007; Pinto et al., 2009). Thus, the quality of life could be
affected by a fungal infection which is usually treated using
antifungal medications. Some of these medications apart from
being costly, have unpleasant side effects and may cause the
resistance of the organisms to the antifungal agent. Conse-
quently, there is a constant search for alternative antifungal
treatments some of which are obtained from medicinal plants.
Medicinal plants form the backbone of traditional/alternative
system of medicine and they have been the subject of re-
search interest for pharmacological studies in the last couple
of decades. This is as a result of the acceptance of the value of
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medicinal plants as a possible source of novel compounds of
therapeutic importance (Prusti et al., 2008). Among plants of
medicinal importance, Ficus exasperata, Annona muricata, and
Azadirachta indica are used for various therapeutic purposes.
Ficus exasperata Vahl. belongs to the family Moraceae and it
is locally known as “sandpaper tree” and “Ewe ipin” in the
Yoruba language of Western Nigeria. Different parts of the
plant are locally used for treating various infectious diseases
such as eye-sores, ringworm, stomach pains and leprosy, etc.
(Bafor and Igbinuwen, 2009). Some pharmacological activities
like anti-hypertensive, antioxidant, anti-inflammatory, anti-
ulcer, anti-lipidic, anti-bacterial, and anti-fungal have been
documented for F. exasperata (Sonibare et al., 2006).
Annona muricata L. belongs to the family Annonaceae, it is lo-
cally called soursop due to the slightly acidic taste of the fruit
when ripe (Hutchinson and Dalziel, 2000). Different parts of
the plants have been previously reported to possess bioactivity.
For instance, its leaves and stem are considered to show cyto-
toxicity against cancer cells as a result of a compound called
acetogenin activity which is not toxic to normal cells (Ober-
lies et al., 1995). Acetogenins and other phytocompounds
present in the plant have collectively exhibited antitumor, par-
asiticidal, pesticidal, and antimicrobial activities (McLaughlin,
2008).
Azadirachta indica A. Juss. commonly-known as neem belongs
to the family Meliaceae. It is indigenous to India and es-
tablished in many of the tropical and subtropical countries
including Nigeria. The plant has been reported to possess
many pharmacological activities such as antioxidant and an-
tifungal among others (Choudhary et al., 2017; Itelima et al.,
2016; Mondall et al., 2009; Nahak and Sahu, 2010).
The bioactive substances in these plants are usually extracted
with a wide range of solvents for various ethnobotanical appli-
cations. The literature is also well supported with information
on the antimicrobial properties of various extracts of F. exas-
perata (Adebayo et al., 2009; Ajayi et al., 2012; Takon, 2013), A.
muricata (Vijayameena et al., 2013) and A. indica (Mohammed
and Omer, 2017). However, none of these studies has reported
the activity of corn steep liquor (CSL) extracts against fungal
species. The CSL which is a by-product of the wet corn milling
process (Abdus-Salaam et al., 2014), and water are commonly
used to prepare herbal decoctions which are utilized in the
treatment and management of various disorders including
fungal infection. In this study, we present findings on the
antifungal activity of aqueous and corn steep extracts of F.
exasperata, A. muricata, and A. indica against vaginal isolates of
Candida species.
2. MATERIALS AND METHODS
2.1. Plant materials and extraction procedures
Leaves samples from F. exasperata, A. muricata and A. indica
were collected in the early hours of the day from the arboretum
of the Department of Forestry and Wildlife Management, Fed-
eral University of Agriculture, Abeokuta, Nigeria. The plant
specimens were identified at the Forest Herbarium Ibadan.
The leaves samples were air-dried for two weeks on a cabinet
dryer and then milled to powdered form. Freshly made corn
steep liquor (CSL), a byproduct of the corn wet milling process,
was obtained from the local makers of pap, the main product
of the wet milling process. Aqueous and CSL extracts were
of the three plants were prepared according to the method
previously used by Pai et al. (2010) with modifications. Sterile
distilled water and CSL (both 500 mL) were used to extract 50
g of the powdered plant samples by boiling for 30 minutes on
a hot plate (100 °C), allowed to cool and filtered using a sterile
filter paper. The concentration of the filtrates was reduced to
a semi-solid mass on a water bath to get the crude extracts
of the three plant samples which were then stored at 4 °C in
preparation for the phytochemical screening and fungal sus-
ceptibility testing of the extracts described in the subsequent
sections.
2.2. Collection and isolation of Candida strains
High vaginal swabs from suspected cases of Candida infection
were obtained from the Federal Medical Centre, Abeokuta.
The obtained swabs containing Candida spp. were cultivated
on potato dextrose agar (PDA) and Candida strains identified
using standard microbiological procedures (Shah et al., 2012;
Galle and Gianinni, 2004). In brief, macroscopic examination
of the cultures considered rate of growth, colonial morphology,
pigment production, texture, and colour of surface or reverse,
while microscopic examination was done using the germ tube
test.
2.3. Phytochemical analysis
Phytochemical screening of the plant extracts was carried
out using standard methods for determination of tannins,
saponins, anthraquinones, flavonoids, and terpenoids’ pres-
ence. In brief, 2 g of the crude extract was re-dissolved in 10
mL of distilled water and CSL, then the presence of tannin
was detected using the ferric chloride test, saponin’s presence
was detected using the Frothing test, anthraquinone was de-
termined using the Bontrager’s test, flavonoid was detected
using the lead acetate test, while terpenoids’ screening was
done using the Salkowski’s test (Harborne, 1973; Obasi et al.,
2010; Roopashree et al., 2008).
2.4. Sensitivity testing of aqueous and corn steep liquor
plant extracts against Candida isolates
Agar well diffusion method was used to test the sensitivity of
the Candida isolates to the aqueous and CSL leaves extracts.
This was done according to the method described by Kareem
et al. (2010). Sterile cotton-wool swab was dipped into pre-
pared inoculum and spread all over PDA plate. After each
swabbing, the swab was passed around the edges of the agar
surface medium and left to dry for few minutes at room tem-
perature with the lid closed. Then, by using a sterile cork borer,
four wells of 4 mm in diameter representing the four concen-
trations (100, 75, 50 and 25 mg/mL) of the sample extracts
were made in the inoculated plate and each well labeled for
each concentration. The three plants’ crude extracts were each
reconstituted with sterile distilled water and CSL to a stock
concentration of 200 mg/mL after which four working con-
centrations of 100, 75, 50 and 25 mg/mL of aqueous and CSL
of extracts of each plant were prepared from the stock then, 50
µL of each concentration was introduced into the respective
wells using a micropipette in the inoculated plates. The plates
were left for half an hour with the lid closed. The plates were
incubated at 28 °C for 24 h and then observed for the zone of
inhibition which is characterized by the clear area around the
well. The experiment was done in triplicates and the zone of
growth inhibition was measured with a transparent ruler and
expressed in millimeters.
2.5. Determination of the minimum inhibitory concentration
of plant extracts on Candida isolates
The modified method of Malwal and Sarin (2011) was em-
ployed for the determination of the minimum inhibitory con-
centration (MIC) of extract using the broth dilution method.
For the broth dilution, the growth concentration was adjusted
to 105 organisms/mL by using 0.5 mL McFarland turbidity
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Table 1. Results of phytochemical screening of aqueous and CSL extracts of the test plants
F. exasperataa A. muricata A. indica
Phytochemical Aqueous CSL Aqueous CSL Aqueous CSL
Tannin + + + + + +
Saponin + + + + + +
Anthraquinone - - - - - -
Flavonoids + + + + + +
Terpenoids + + + + + +
a Signs ’+’ and ’-’ denote presence and absence, respectively.
standard. Aqueous and CSL solution of 25 % was prepared
from the leaves extracts as the stock solution. Potato dextrose
broth (5 mL) was added in MIC tubes. One milliliter of plant
extracts stock was added to each tube containing the broth
at various concentrations (25, 12.5, 6.25 and 3.125 %). The
tubes were incubated at 28 °C for 48 hours and observed for
visible growth after shaking the tubes gently to mix. The ex-
periment was done in duplicate. The MIC was taken as the
lowest concentration of the extracts at which there is no tur-
bidity after incubation. The negative control containing only
broth appeared clear.
2.6. Determination of the minimum fungicidal concentration
(MFC) of plant extracts on Candida isolates
This is usually carried out after MIC test, to determine the
minimum concentration of the test antifungal agent that will
kill the microorganism. The contents of the MIC wells were
inoculated on sterile PDA separately. The plates were labeled
indicating the well from which the isolate was plated and
incubated at 28 °C for 48 hours for growth. Plates that showed
growth of organisms were checked to determine the wells
from which they were inoculated. The lowest concentration of
the wells from which the plates were inoculated that did not
show any growth was considered as the MFC of the organism
(Levinson, 2016).
2.7. Antifungal susceptibility pattern
Antibiogram was performed using the method of Clinical and
Laboratory Standards Institute (Kanthasamy et al., 1989). An
inoculum was prepared and its turbidity was adjusted visually
with the transmittance to that produced by a 0.5 McFarland
standard. After obtaining the 0.5 McFarland standards for iso-
lated species of Candida they were swabbed uniformly on the
surface of Muller Hinton agar and allowed to dry under sterile
conditions. After drying, antifungal discs of three commercial
antibiotics namely Amphotericin B, Fluconazole and Keto-
conazole were placed onto the surface of inoculated plates of
Candida. The plates were incubated at 35 °C for 24 hours and
after incubation zones of growth inhibition were measured,
results were recorded as susceptible or resistant.
3. RESULTS
In other to assess the antifungal effects of CSL and aqueous
extracts of three medicinal plants on clinical isolates of Can-
dida spp., high vaginal swab samples obtained from suspected
cases of candidiasis were used to isolate and test the poten-
tial effect of the tested extracts against the isolated organisms
adopting the agar well diffusion method. Results from the
high vaginal swab samples revealed that three Candida species
were identified. One strain of C. albicans has been identified,
while C. kefyr and C. krusei had two strains each. The morpho-
logical analysis of the three species showed that isolates had
cream colour, spherical shape and the surface margin entire.
C. albicans had a flat elevation while the strains of C. kefyr
and C. krusei had a raised elevation. The biochemical analysis
showed that the three species were urea negative. C. kefyr and
C. krusei were also germ tube negative, while C. albicans was
germ tube positive. The results of the phytochemical screen-
ing of the aqueous and CSL extracts of the species F. exasperata,
A. muricata and A. indica are presented in Table 1. The results
show the presence of all observed phytochemical compounds
except anthraquinone.
The inhibitory activity of the aqueous and CSL extracts of
tested medicinal plants against the isolated strains of Candida
spp. is represented in Table 2. The mean zone of inhibition
produced by the plant extracts against C. albicans show that for
F. exasperata it ranged from 0-16.8 mm, for A. muricata ranged
from 9.1-18.3 mm while for A. indica it ranged from 0-10.4 mm;
the mean zone of inhibition observed in C. krusei (Strain A)
indicate that for F. exasperata it ranged from 9.8-24.5 mm, for
A. muricata it ranged from 9.4-23.4 mm while for A. indica it
ranged from 5.3-14.4 mm; the mean zones of inhibition pro-
duced against C. krusei (Strain B) revealed that for F. exasperata
it ranged from 0-18.0 mm, for A. muricata it ranged from 8.2-
17.5 mm compared while for A. indica it ranged from 0-11.8
mm. Also, the mean inhibition zones produced against C. kefyr
(Strain A) revealed that for F. exasperata it ranged from 10.3-
25.1 mm, for A. muricata it ranged from 18.4-27.5 mm while for
A. indica it ranged from 6.1-16.3 mm; against against C. kefyr
(Strain B), the mean zones of inhibition revealed that for F.
exasperata it ranged from 0-19.1 mm, for A. muricata it ranged
from 2.1-22.0 mm while for A. indica it ranged from 0-16.4
mm. Both aqueous and CSL extracts of A. muricata had higher
inhibitory activity compared with the other plants against all
the Candida spp. while the least inhibitory effect was observed
in A. indica.
The results of the antifungal sensitivity testing of the Candida
strains against three commercial antibiotics are also shown
in Table 2. Amphotericin B had the most sticking antifungal
effect against the five strains of Candida spp. with the growth
inhibition zone ranging from 15.0-21.0 mm while fluconazole
had inhibitions on only the two strains of C. kefyr, while all
the Candida strains demonstrated significant susceptibility to
Ketonidazole except C. albicans. The result also suggests that
the CSL extracts of A. muricata at the concentration range of
50-100 mg/mL showed better antifungal activity against the C.
kefyr (Strain A) when compared with the standard antifungal
drugs.
The results of the Minimum Inhibitory Concentrations (MICs)
and Minimum Fungicidal Concentration (MFC) of the plant
extracts against the tested Candida strains are presented in
Table 3. The MICs of the aqueous and CSL extracts of the three
medicinal plants were obtained by the broth dilution method
where the MICs were determined as the lowest concentration
of aqueous and CSL extracts that gave sterile culture after
incubation. The MIC of the aqueous and CSL extracts of the
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Table 2. Mean inhibition zone (mm) of Candida species after application of aqueous and CSL extracts of F. exaperasta, A.
muricata, and A. indica with commercial antibiotics as a control
Extract Conc. C. albicans C. krusei C. kefyr
Species [mg/mL] Strain A Strain B Strain A Strain B
F. exasperata Aqueous 25 - 9.8.±0.9 6.2±0.6 17.2±1.7 -
CSL 25 6.0±0.2 14.1±0.8 - 10.3±0.6 14.1±1.4
Aqueous 50 3.3±0.6 11.7±1.4 9.2±1.3 19.4±1.2 10.0±1.0
CSL 50 10.6±1.3 18.2±1.9 12.5±1.0 13.1±0.5 17.2±2.1
Aqueous 75 10.3±0.8 16.3±1.2 11.9±0.8 24.3±2.0 14.4±1.4
CSL 75 14.2±1.7 20.6±1.3 18.0±1.4 18.3±0.8 19.1±1.3
Aqueous 100 13.1±0.9 21.3±1.7 15.1±1.2 25.1±1.9 15.7±0.8
CSL 100 16.8±1.4 24.5±2.3 11.8±1.3 23.0±1.6 17.6±1.5
A. muricata Aqueous 25 9.1±1.1 12.1±0.8 8.2±0.7 19.2±2.2 2.1±0.5
CSL 25 11.5±0.6 9.4±0.8 12.2±0.7 18.4±1.4 11.4±1.1
Aqueous 50 12.4±1.2 16.2±1.2 8.2±1.4 22.0±1.7 5.0±0.5
CSL 50 14.1±0.5 17.3±1.2 13.5±1.5 23.4±2.1 18.0±1.2
Aqueous 75 15.3±0.9 22.2±1.7 14.1±1.2 23.8±1.4 12.1±1.8
CSL 75 16.2±1.4 18.1±0.8 14.3±0.7 24.1±1.6 17.2±1.6
Aqueous 100 17.7±1.5 22.7±1.6 17.0±0.8 25.5±1.8 14.3±1.2
CSL 100 18.3±1.8 23.4±1.8 17.5±1.2 27.5±0.6 22.0±1.7
A. indica Aqueous 25 - 5.3±0.6 - 6.1±0.4 -
CSL 25 - 5.9±0.3 2.0±0.6 7.2±0.8 -
Aqueous 50 - 10.0±1.5 - 10.3±1.6 4.2±0.4
CSL 50 - 6.8±0.4 6.4±1.4 9.1±0.4 8.1±0.8
Aqueous 75 - 11.2±0.8 4.2±0.8 11.7±0.8 7.8±1.2
CSL 75 7.5±0.7 11.8±1.3 11.4±1.4 11.4±1.1 10.3±1.4
Aqueous 100 - 13.3±1.2 9.0±0.9 14.2±1.2 12.2±0.9
CSL 100 10.4±1.6 14.4±0.7 11.8±1.6 16.3±0.8 16.4±1.3
Antibiotics [µg/mL]
Fluconazole 10 - - - 20.3±0.7 15.2±1.1
Ketonidazole 10 - 17.2±0.1 19.1±0.2 22.0±1.5 18.2±0.8
Amphotericin B 10 21.0±0.2 20.3±0.1 15.0±0.5 19.4±1.8 18.1±1.2
Table 3. Minimum inhibitory concentration (MIC) (mg/mL) and minimum fungicidal concentrations (MFC)
(mg/mL) of aqueous and CSL extracts of test plants against isolates of Candida species
Test Species Strain F. exasperata A. muricata A. indica
Aqueous CSL Aqueous CSL Aqueous CSL
MIC C. albicans - - 12.5 12.5 12.5 - -
C. krusei Strain A 12.5 6.25 6.25 6.25 - -
Strain B 12.5 6.25 6.25 6.25 - -
C. kefyr Strain A 12.5 6.25 6.25 3.125 25 12.5
Strain B 6.25 6.25 6.25 3.125 25 12.5
MFC C. albicans - - 25 25 25 - -
C. krusei Strain A 25 12.5 12.5 12.5 - -
Strain B 25 12.5 12.5 12.5 - -
C. kefyr Strain A 25 12.5 12.5 6.25 - 25
Strain B 12.5 12.5 12.5 6.25 - 25
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F. exasperata ranged between 6.25-12.5 mg/mL, though the
aqueous extract was found to have no activity against cultures
of C. albicans, The MIC for CSL and aqueous extracts of A.
muricata ranged from 3.125-12.5 mg/mL, while the aqueous
and CSL extracts of A. indica were found to have no activity at
all the tested concentrations against C. albicans, C. krusei (Strain
A) and C. krusei (Strain B). The MFC of both aqueous and CSL
extracts was determined as the lowest concentration of the
plant extracts that did not permit any visible growth of the
inoculated test organism in broth culture. The aqueous extract
of F. exasperata recorded no inhibition against C. albicans at
the tested concentration range while the MFC of the aqueous
and CSL extract against the other strains ranged from 12.5-25
mg/mL. The aqueous extract of A. indica gave no inhibition at
the tested concentration range.
4. DISCUSSION
Many communities in the developing world continue to rely
on the use of herbs for primary health care purposes. In the
traditional medicinal applications, water and CSL are two of
the commonly used solvent to prepare herbal decoction used
to treat various ailments including fungal infection. Data avail-
able from the literature indicates that little or no information
is available on the antifungal activity of the CSL extracts of
the studied plants. Thus, in this study, the antifungal activity
of the aqueous and CSL extracts of F. exasperata, A. muricata,
A. indica were tested against Candida species isolated from
high vaginal swab (HVS) samples. The presence of Candida
in the HVS was ascertained, the genus Candida often forms
the normal flora of the vagina, where some species may be-
come opportunistic pathogens, if the defence mechanism of
the host is weak (Bader et al., 2003). These Candida species in
the vaginal flora are known to be responsible for candidiasis
under low immunity. Three species of Candida (C. albicans,
C. kefyr and C. krusei) were isolated from high vaginal swab
samples, this agrees with previously reported studies in many
countries that demonstrated that some of the prevalent yeast
isolated from HVS were C. albicans, C. krusei and C. kefyr (Astic-
cioli et al., 2009; Ellabib and ElJariny, 2001; Hamza et al., 2008;
Mohanty et al., 2007). Candidiasis has often been treated in
hospitals with antibiotics. However, some reports have been
published on the increasing development of resistance of mi-
croorganisms to antibiotics (Levy, 2002). Furthermore, studies
have also shown that antibiotics usage for different human
ailments including prophylactic and preventive purposes as
well as the general well-being of the body have contributed
to the increasing rise in resistance to antibiotics (Kothavade
et al., 2010). Thus, it is not surprising that Candida species
isolated from this study showed varying reactions to the com-
mercially available antibiotics. C. albicans was found to be
susceptible to Amphotericin B with the zone of inhibition of
21 mm while it was resistant to Fluconazole and Ketonidazole.
The results of this study are consistent with a previous study
which also suggest susceptibility pattern of Candida species to
a diverse range of antibiotic (Hamza et al., 2008). The result
from the antifungal testing of the aqueous and CSL extract
of the studied plants suggests that both F. exasperata and A.
muricata had a possible antifungal effect against the isolated
Candida strains at higher concentration showing a partial dose-
dependent trend, the CSL extract was found to particularly
elicit greater antifungal effect that the aqueous extracts. It
seems possible that this may be due to the presence of lac-
tic acid bacteria and other bioactive components in the CSL
which may have contributed to the increased extractive ability
of the bioactive substances present in the medicinal plants.
Furthermore, it is noteworthy that CSL on its own has been
demonstrated to possess antibacterial activity (Abdus-Salaam
et al., 2014); other solvent extracts of F. exasperata root bark
have also been reported to possess significant activity against
Candida species (Lawal et al., 2012), this corresponds with the
findings in this study for both the aqueous and CSL leave ex-
tracts of F. exasperata. At lower concentration, the aqueous ex-
tract of A. indica was found to have little or no activity against
C. albicans, C. kefyr (Strain B), and C. krusei (Strain B), while a
dose-dependent inhibition was observed against C. albicans by
the CSL extract of A. muricata. This trend is in agreement with
the observations reported by Olaiya et al. (2016) where CSL
extracts of Citrullus colocynthis, Curculigo pilosa and Gladiolus
psittacinus demonstrated significant antibacterial effect against
Staphylococcus aureus, Escherichia coli, Klebsiella pneumonae and
Salmonella typhi. However, F. exasperata extract was reported
to have no activity against C. albicans in the study by Adebayo
et al. (2009) which is contrary to the findings in this study;
this may be a reflection of the effect of the different solvent
type used in the study. Various solvent extracts of A. muricata
have been shown to exhibit antibacterial activity (Vijayameena
et al., 2013). The findings in this study also matched those
observed in the study by Pai et al. (2010) where an aqueous ex-
tract of A. muricata was reported to be highly effective against
Candida species; it is also noteworthy that both aqueous and
CSL extracts of A. muricata showed better activity against C.
kefyr (Strain A) than all the conventional antibiotics. The min-
imal antifungal activity of A. indica extracts observed in this
study mirrors those reported by Mahmoud et al. (2011) where
little activity was found against C. albicans, though, in another
study, tissue conditional mixed with A. indica extracts at two
concentrations was reported to exhibit considerable poten-
tial effectiveness against C. albicans (Barua et al., 2017). The
MIC values revealed that the aqueous and CSL leave extracts
of the F. exasperata inhibited the growth of four of the tested
pathogens within range of 6.25-12.5 mg/mL. The MIC for the
aqueous and CSL extract of A. muricata ranged between 6.25-
12.5 mg/mL and 3.125-12.5 mg/mL respectively, this shows
the potential of the plant extract to inhibit the growth of the
human fungal pathogens, however, only two of the Candida
species gave a MIC value for A. indica extracts with the CSL
extract inhibiting both strains of C. kefyr at a concentration of
12.25 mg/mL and no inhibition observed at the tested concen-
tration ranged against the other Candida strains. In the same
manner, the fungicidal effect of the tested extracts shows that
only the aqueous extract of F. exasperata did not demonstrate a
fungicidal effect against C. albicans at the tested concentration
range. The MFC of the plant extracts tends towards the mid
concentration for most of the plant extracts that showed activ-
ity with CSL extract of A. indica only demonstrating fungicidal
action at 25 mg/mL against the two strains of C. kefyr. This
observation justifies the use of this plant as an antimicrobial
agent in traditional medicine. The antifungal activity shown
by the extracts of the studied plants may be attributed to the
presence of the secondary metabolites that were detected to
be present in both the aqueous and CSL extracts of the F. exas-
perata, A. muricata and A. indica, this observation also supports
the findings in other similar studies on different extracts of
the studied plants (Iyanda-Joel et al., 2019; Nimenibo-uadia,
2017; Saleh Al-Hashemi and Hossain, 2016; Vijayameena et al.,
2013). Some researchers have demonstrated the antifungal ef-
fects of various forms of tannin tested against a wide range of
fungi including Candida species (Morey et al., 2016; Latté and
Kolodziej, 2000), similarly, saponin rich extracts isolated from
plants have also been reported to have good activity against
Candida species (Coleman et al., 2010; Tsuzuki et al., 2007; Yang
et al., 2006; 2018); likewise, the bioactivity of flavonoids and
polyphenolics against Candida species have been documented
(Patuwo et al., 2014; Salazar-Aranda et al., 2015). These evi-
dence suggest that the antifungal activity elicited by the CSL
and aqueous extracts of the plants may be due to the pres-
Research Article Natural Medicinal Materials vol. 40 (2020) 10
ence of these phytochemicals whether working alone or in
synergy which could therefore, justify their folkloric use in
alternative medicine. However, further studies are needed to
isolate specific phytochemical compounds present in the CSL
and aqueous extracts of the plants which may be responsible
for the antifungal activity.
CONCLUSION
This study has shown the antifungal efficacy of aqueous and
CSL extracts of F. exasperata, A. muricata, and A. indica against
isolates of Candida species which are usually implicated in
candidiasis, thereby providing additional evidence on the
antimicrobial activity of CSL extracts of the plants; this has
been attributed to its phytochemical extractive ability which
is known to elicit antifungal activities.
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